Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
Repeat vaccination against COVID-19: risk groups first, then everyone 12 and up The first invitations for a repeat vaccination against COVID-19 will be received by people in the Netherlands on 13 September 2022. RIVM will invite the oldest people first, and will then send an invitation to everyone aged 60 years and older.
Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
New data on antimicrobial resistance in Europe New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw
International collaboration essential theme State of Zoonoses 2019 Each year, at the request of the Netherlands Food and Consumer Product Safety Authority, RIVM prepares an overview of the most important zoonoses and indicates their prevalence in the Netherlands.
Climate and Energy Outlook 2020: uncertain whether the Netherlands will achieve targets for the reduction of greenhouse gas emissions The Dutch cabinet’s goal is to reduce greenhouse gas emissions by 49% in 2030, compared to the levels in 1990.